Organization

Rheumatology, Leiden University Medical Centre, Leiden, Netherlands, University Erlangen-Nurnberg, Erlangen, Charite Humboldt University, Berlin, Abbott GmbH Co. KG, Ludwigshafen, Germany

4 abstracts

Abstract
ADALIMUMAB (HUMIRA®) IS EFFECTIVE IN TREATING PATIENTS WITH RHEUMATOID ARTHRITIS WHO PREVIOUSLY FAILED INFLIXIMAB TREATMENT
Org: Rheumatology, Leiden University Medical Centre, Leiden, Netherlands, University Erlangen-Nurnberg, Erlangen, Charite Humboldt University, Berlin, Abbott GmbH Co. KG, Ludwigshafen, Germany,
Abstract
ANTI-CARBAMYLATED ANTIBODIES IN CANADIAN FIRST NATION RA PATIENTS, FIRST DEGREE RELATIVES AND CONTROLS IN RELATION TO ACPA AND RF PRESENCE AND ACPA EPITOPE SPREAD
Org: Rheumatology, Leiden University Medical Centre, Leiden, Netherlands, University Erlangen-Nurnberg, Erlangen, Charite Humboldt University, Berlin, Abbott GmbH Co. KG, Ludwigshafen, Germany, Rheumatology, University of Manitoba, Winnipeg, Canada, Stanford University, Stanford, United States of America,
Abstract
Axspa patient with peripheral manifestations
Org: Rheumatology, Leiden University Medical Centre, Leiden, Netherlands, University Erlangen-Nurnberg, Erlangen, Charite Humboldt University, Berlin, Abbott GmbH Co. KG, Ludwigshafen, Germany,
Abstract
BEFORE CLINICALLY DETECTABLE ARTHRITIS DEVELOPS, ACPA-POSITIVE AND ACPA-NEGATIVE ARTHRALGIA PATIENTS HAVE DIFFERENT SYMPTOMS
Org: Rheumatology, Leiden University Medical Centre, Leiden, Netherlands, University Erlangen-Nurnberg, Erlangen, Charite Humboldt University, Berlin, Abbott GmbH Co. KG, Ludwigshafen, Germany,